Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern ...

VANCOUVER , Dec. 22, 2014 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP) , a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced ...

0 komentar:

Posting Komentar